Study of TS-1 or TS-1 + PSK for Gastric Cancer Patients (TMOG-GC01)
|ClinicalTrials.gov Identifier: NCT00687843|
Recruitment Status : Unknown
Verified March 2012 by Yoshiaki Iwasaki, M.D., Ph.D., Tokyo Metropolitan Oncology Group.
Recruitment status was: Active, not recruiting
First Posted : June 2, 2008
Last Update Posted : March 22, 2012
Tokyo Metropolitan Oncology Group
Information provided by (Responsible Party):
Yoshiaki Iwasaki, M.D., Ph.D., Tokyo Metropolitan Oncology Group
No Study Results Posted on ClinicalTrials.gov for this Study
|Recruitment Status :||Unknown|
|Estimated Primary Completion Date :||March 2016|
|Estimated Study Completion Date :||March 2016|
Sakuramoto S, Sasako M, Yamaguchi T, Kinoshita T, Fujii M, Nashimoto A, Furukawa H, Nakajima T, Ohashi Y, Imamura H, Higashino M, Yamamura Y, Kurita A, Arai K; ACTS-GC Group. Adjuvant chemotherapy for gastric cancer with S-1, an oral fluoropyrimidine. N Engl J Med. 2007 Nov 1;357(18):1810-20. Erratum in: N Engl J Med. 2008 May 1;358(18):1977.